株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

オリゴヌクレオチド合成の世界市場 - 2022年までの予測:プライマー、プローブ、リンカー、アダプター、カスタムオリゴ、試薬、機器

Oligonucleotide Synthesis Market by Product (Primer, Probe, Linker, Adaptor, Custom, Reagent, Equipment), Application (PCR, DNA, RNAi, Research, Therapeutic), End User (Academic, Pharmaceutical, Biotechnology) - Global Forecast to 2022

発行 MarketsandMarkets 商品コード 311580
出版日 ページ情報 英文 274 Pages
即納可能
価格
本日の銀行送金レート: 1USD=108.48円で換算しております。
Back to Top
オリゴヌクレオチド合成の世界市場 - 2022年までの予測:プライマー、プローブ、リンカー、アダプター、カスタムオリゴ、試薬、機器 Oligonucleotide Synthesis Market by Product (Primer, Probe, Linker, Adaptor, Custom, Reagent, Equipment), Application (PCR, DNA, RNAi, Research, Therapeutic), End User (Academic, Pharmaceutical, Biotechnology) - Global Forecast to 2022
出版日: 2018年02月06日 ページ情報: 英文 274 Pages
概要

世界のオリゴヌクレオチド合成市場は、2017年の14億7000万米ドルから、2022年までに24億6000万米ドルまで拡大すると見られています。市場は、2017年〜2022年のCAGR (複合年間成長率) で、10.9%の成長が予測されています。

当レポートでは、世界のオリゴヌクレオチド合成市場について調査分析し、市場概要、産業動向、セグメント別の市場分析、競合情勢、主要企業などについて、体系的な情報を提供しています。

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

  • オリゴヌクレオチド合成市場の魅力的な機会
  • オリゴヌクレオチド合成市場:製品別
  • オリゴヌクレオチド合成市場:タイプ別
  • 欧州のオリゴヌクレオチド合成市場:研究用途・国別
  • オリゴヌクレオチド合成市場:治療用途別
  • オリゴヌクレオチド合成市場:エンドユーザー別
  • 地域別スナップショット:オリゴヌクレオチド合成市場

第5章 市場概要

  • イントロダクション
  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場課題
  • 産業動向

第6章 オリゴヌクレオチド合成の世界市場:製品別

  • イントロダクション
  • 合成オリゴヌクレオチド
    • 製品別
    • タイプ別
  • 試薬
  • 機器

第7章 オリゴヌクレオチド合成の世界市場:用途別

  • イントロダクション
  • 研究
  • 診断
  • 治療

第8章 オリゴヌクレオチド合成の世界市場:エンドユーザー別

  • イントロダクション
  • 学術研究機関
  • 製薬・バイオ企業
  • 臨床検査室
  • その他

第9章 オリゴヌクレオチド合成の世界市場:地域別

  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東・アフリカ

第10章 競合情勢

  • 概要
  • 市場シェア分析
  • 競合シナリオ

第11章 企業プロファイル

  • INTEGRATED DNA TECHNOLOGIES
  • MERCK KGAA
  • EUROFINS GENOMICS
  • THERMO FISHER SCIENTIFIC
  • BIOAUTOMATION
  • AGILENT TECHNOLOGIES
  • EUROGENTEC
  • GE HEALTHCARE
  • LGC BIOSEARCH TECHNOLOGIES
  • NITTO DENKO AVECIA
  • GENSCRIPT
  • GENEDESIGN (味の素の一部)
  • TRILINK BIOTECHNOLOGIES (MARAVAI LIFESCIENCESの一部)
  • BIO-SYNTHESIS
  • ATDBIO

第12章 付録

目次
Product Code: BT 2680

"The global oligonucleotide synthesis market projected to grow at a CAGR of 10.9%."

The global oligonucleotide synthesis market is expected to reach USD 2.46 billion by 2022 from USD 1.47 billion in 2017 at a CAGR of 10.9%. This market is experiencing significant growth due to the increasing research activities in the pharma and biotech sectors and the rising demand for innovative diagnostic and therapeutic techniques.

Growth in this market is mainly driven the increasing R&D expenditure by pharmaceutical and biotechnology companies, rising demand for synthesized oligonucleotides from the growing field of molecular diagnostics, rising venture capital investments, and increasing demand for synthetic genes. However, the price erosion of synthesized oligos and lack of regulations for therapeutic oligos are some factors that may hinder the growth of this market.

"Synthesized oligonucleotides are expected to grow at the highest CAGR during the forecast period."

Based on product, the market is segmented into synthesized oligonucleotides, reagents, and equipment. The synthesized oligonucleotides segment is expected to grow at the highest CAGR during the forecast period The increasing number of applications of synthesized oligonucleotides in research, diagnostics, and therapeutics is a key market driver in this segment. The rising availability and demand for custom oligos also contribute to the growth of the synthesized oligonucleotides market.

"The research segment is expected to hold the largest share of the market in 2017."

Based on application, the market is segmented into research, diagnostics, and therapeutics. The research segment is estimated to hold the largest share of the oligonucleotide synthesis market in 2017. The market growth for research applications is mainly driven by the developments in the fields of gene synthesis and NGS. Oligos are widely used in technologies such as PCR, qPCR, gene synthesis, isothermal nucleic acid amplification technology (INAAT), microarray, hybridization, DNA sequencing, and next-generation sequencing (NGS).

"Academic research institutes are expected to dominate the market during the forecast period."

Based on end user, the market is segmented into academic research institutes, pharmaceutical and biotechnology companies, diagnostic laboratories, and other end users. The academic research institutes segment is expected to dominate the market during the forecast period. With the increasing funding pouring into institutes to conduct research, the demand for oligonucleotides is bound to increase. To meet this need, companies are launching products and entering into agreements with different research institutes to supply oligonucleotides for research purposes. For instance, in August 2015, Eurofins Genomics launched NGS tests for the identification of non-targeted microorganisms, including 16S Microbiome Profiling for academia and research.

"APAC to witness the highest growth during the forecast period."

In 2017, North America is expected to account for the largest share of the market followed by Europe. However, Asia Pacific is expected to register the highest CAGR during the forecast period. This can be attributed to factors such as the growing availability of synthesized oligos, along with an increase in R&D funding and activities in the APAC region. The increasing focus of prominent players on APAC is also supporting market growth in the region.

The primary interviews conducted for this report can be categorized as follows:

  • By Company Type: Tier 1 - 36%; Tier 2 - 46%; Tier 3 - 18%.
  • By Designation: C-level- 26%; D-level- 45%; Others- 29%.
  • By Region: North America-41%; Europe-31%; Asia Pacific-20%; Latin America- 5%, Middle East and Africa-3%

List of companies profiled in the report:

  • Agilent Technologies (US)
  • ATDBio (UK)
  • Bio-Synthesis (US)
  • BioAutomation (US)
  • LGC Biosearch Technologies (US)
  • Eurofins Genomics (Germany)
  • Eurogentec (Belgium)
  • GeneDesign (Japan)
  • GE Healthcare (US)
  • GenScript (US)
  • Integrated DNA Technologies (IDT) (US)
  • Nitto Denko Avecia (US)
  • Thermo Fisher Scientific (US)
  • TriLink Biotechnologies (US)
  • Sigma-Aldrich Corporation (Sigma-Aldrich) (US) (part of Merck KGAA (Germany)

Research Coverage:

The report provides an overview of the oligonucleotide synthesis market. It aims at estimating the market size and future growth potential of this market across different segments such as product, application, end user, and region. Furthermore, the report also includes an in-depth competitive analysis of the key players in the market along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:

The report will help the market leaders/new entrants in this market by providing them with the closest approximations of revenues for the overall oligonucleotide synthesis market and its subsegments. This report will help stakeholders to understand the competitive landscape better and gain insights to position their businesses and help companies make suitable go-to-market strategies. The report also will also help stakeholders understand the pulse of the market and provide them with information regarding key market drivers and opportunities.

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH DATA
  • 2.2. SECONDARY DATA
    • 2.2.1. SECONDARY SOURCES
  • 2.3. PRIMARY DATA
    • 2.3.1. KEY DATA FROM PRIMARY SOURCES
    • 2.3.2. KEY INDUSTRY INSIGHTS
  • 2.4. MARKET SIZE ESTIMATION
    • 2.4.1. MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
    • 2.4.2. MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
  • 2.5. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.6. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. ATTRACTIVE OPPORTUNITIES IN OLIGONUCLEOTIDE SYNTHESIS MARKET
  • 4.2. OLIGONUCLEOTIDES SYNTHESIS MARKET, BY SYNTHESIZED OLIGONUCLEOTIDES PRODUCTS
  • 4.3. OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SYNTHESIZED OLIGONUCLEOTIDES TYPE
  • 4.4. EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY RESEARCH APPLICATION AND COUNTRY
  • 4.5. OLIGONUCLEOTIDE SYNTHESIS MARKET, BY THERAPEUTIC APPLICATION
  • 4.6. OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER
  • 4.7. GEOGRAPHIC SNAPSHOT: OLIGONUCLEOTIDE SYNTHESIS MARKET

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DRIVERS
    • 5.2.1. INCREASING USE OF SYNTHESIZED OLIGONUCLEOTIDES IN MOLECULAR DIAGNOSTICS AND CLINICAL APPLICATIONS
    • 5.2.2. INCREASING GOVERNMENT INVESTMENTS AND R&D EXPENDITURE IN PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
    • 5.2.3. RISE IN VENTURE CAPITAL INVESTMENTS
  • 5.3. MARKET RESTRAINTS
    • 5.3.1. PRICE EROSION OF SYNTHESIZED OLIGONUCLEOTIDES
    • 5.3.2. LACK OF A UNIFIED SET OF REGULATIONS FOR THERAPEUTIC OLIGONUCLEOTIDES
  • 5.4. MARKET OPPORTUNITIES
    • 5.4.1. EMERGING ASIAN MARKETS
  • 5.5. MARKET CHALLENGES
    • 5.5.1. LARGE-SCALE SYNTHESIS OF OLIGONUCLEOTIDES
    • 5.5.2. DELIVERY OF OLIGONUCLEOTIDE DRUGS TO SPECIFIC TARGETS
  • 5.6. INDUSTRY TRENDS

6. OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT

  • 6.1. INTRODUCTION
  • 6.2. SYNTHESIZED OLIGONUCLEOTIDES
    • 6.2.1. BY PRODUCT
      • 6.2.1.1. Primers
      • 6.2.1.2. Probes
      • 6.2.1.3. Large-scale synthesis oligonucleotides
      • 6.2.1.4. Intermediate-scale synthesis oligonucleotides
      • 6.2.1.5. Linkers & Adaptors
    • 6.2.2. BY TYPE
      • 6.2.2.1. Custom oligonucleotides
      • 6.2.2.2. Pre-designed oligonucleotides
  • 6.3. REAGENTS
  • 6.4. EQUIPMENT

7. OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION

  • 7.1. INTRODUCTION
  • 7.2. RESEARCH
    • 7.2.1. PCR
    • 7.2.2. QPCR
    • 7.2.3. SEQUENCING
    • 7.2.4. GENE SYNTHESIS
    • 7.2.5. OTHER RESEARCH APPLICATIONS
  • 7.3. DIAGNOSTICS
  • 7.4. THERAPEUTICS
    • 7.4.1. RNAI
    • 7.4.2. NUCLEIC ACID APTAMERS
    • 7.4.3. DNA/ANTISENSE OLIGONUCLEOTIDES
    • 7.4.4. IMMUNOTHERAPY APPLICATIONS

8. OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER

  • 8.1. INTRODUCTION
  • 8.2. ACADEMIC RESEARCH INSTITUTES
  • 8.3. PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
  • 8.4. DIAGNOSTIC LABORATORIES
  • 8.5. OTHER END USERS

9. OLIGONUCLEOTIDE SYNTHESIS MARKET, BY REGION

  • 9.1. INTRODUCTION
  • 9.2. NORTH AMERICA
    • 9.2.1. US
    • 9.2.2. CANADA
  • 9.3. EUROPE
    • 9.3.1. GERMANY
    • 9.3.2. FRANCE
    • 9.3.3. UK
    • 9.3.4. REST OF EUROPE (ROE)
  • 9.4. ASIA PACIFIC (APAC)
    • 9.4.1. CHINA
    • 9.4.2. JAPAN
    • 9.4.3. INDIA
    • 9.4.4. REST OF ASIA PACIFIC (ROAPAC)
  • 9.5. LATIN AMERICA
    • 9.5.1. BRAZIL
    • 9.5.2. MEXICO
    • 9.5.3. REST OF LATIN AMERICA
  • 9.6. MIDDLE EAST & AFRICA

10. COMPETITIVE LANDSCAPE

  • 10.1. OVERVIEW
  • 10.2. MARKET SHARE ANALYSIS
  • 10.3. COMPETITIVE SCENARIO
    • 10.3.1. PARTNERSHIPS, AGREEMENTS, CONTRACTS, AND COLLABORATIONS
    • 10.3.2. PRODUCT LAUNCHES, UPGRADES, AND APPROVALS
    • 10.3.3. EXPANSIONS
    • 10.3.4. ACQUISITIONS

11. COMPANY PROFILES (Business Overview, Products Offered, Recent Developments, SWOT Analysis, Mnm View)*

  • 11.1. INTEGRATED DNA TECHNOLOGIES
  • 11.2. MERCK KGAA
  • 11.3. EUROFINS GENOMICS
  • 11.4. THERMO FISHER SCIENTIFIC
  • 11.5. BIOAUTOMATION
  • 11.6. AGILENT TECHNOLOGIES
  • 11.7. EUROGENTEC
  • 11.8. GE HEALTHCARE
  • 11.9. LGC BIOSEARCH TECHNOLOGIES
  • 11.10. NITTO DENKO AVECIA
  • 11.11. GENSCRIPT
  • 11.12. GENEDESIGN (PART OF AJINOMOTO)
  • 11.13. TRILINK BIOTECHNOLOGIES (PART OF MARAVAI LIFESCIENCES)
  • 11.14. BIO-SYNTHESIS
  • 11.15. ATDBIO

*Business Overview, Products Offered, Recent Developments, SWOT Analysis, Mnm View might not be captured in case of unlisted companies.

12. APPENDIX

  • 12.1. INSIGHTS FROM INDUSTRY EXPERTS
  • 12.2. DISCUSSION GUIDE
  • 12.3. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.4. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 12.5. AVAILABLE CUSTOMIZATIONS
  • 12.6. RELATED REPORTS
  • 12.7. AUTHOR DETAILS

LIST OF TABLESU

  • TABLE 1: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR SYNTHESIZED OLIGONUCLEOTIDES, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 2: NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR SYNTHESIZED OLIGONUCLEOTIDES, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 3: EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR SYNTHESIZED OLIGONUCLEOTIDES, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 4: ASIA PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR SYNTHESIZED OLIGONUCLEOTIDES, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 5: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR SYNTHESIZED OLIGONUCLEOTIDES, BY PRODUCT TYPE, 2015-2022 (USD MILLION)
  • TABLE 6: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR PRIMERS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 7: NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR PRIMERS, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 8: EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR PRIMERS, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 9: ASIA PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR PRIMERS, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 10: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR PROBES, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 11: NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR PROBES, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 12: EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR PROBES, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 13: ASIA PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR PROBES, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 14: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR LARGE-SCALE SYNTHESIS OLIGONUCLEOTIDES, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 15: NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR LARGE-SCALE SYNTHESIS OLIGONUCLEOTIDES, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 16: EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR LARGE-SCALE SYNTHESIS OLIGONUCLEOTIDES, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 17: ASIA PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR LARGE-SCALE SYNTHESIS OLIGONUCLEOTIDES, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 18: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR INTERMEDIATE-SCALE SYNTHESIS OLIGONUCLEOTIDES, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 19: NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR INTERMEDIATE-SCALE SYNTHESIS OLIGONUCLEOTIDES, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 20: EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR INTERMEDIATE-SCALE SYNTHESIS OLIGONUCLEOTIDES, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 21: ASIA PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR INTERMEDIATE-SCALE SYNTHESIS OLIGONUCLEOTIDES, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 22: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR LINKERS & ADAPTORS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 23: NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR LINKERS & ADAPTORS, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 24: EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR LINKERS & ADAPTORS, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 25: ASIA PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR LINKERS & ADAPTORS, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 26: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR SYNTHESIZED OLIGONUCLEOTIDES, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 27: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR CUSTOM OLIGONUCLEOTIDES, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 28: NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR CUSTOM OLIGONUCLEOTIDES, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 29: EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR CUSTOM OLIGONUCLEOTIDES, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 30: ASIA PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR CUSTOM OLIGONUCLEOTIDES, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 31: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR PRE-DESIGNED OLIGONUCLEOTIDES, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 32: NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR PRE-DESIGNED OLIGONUCLEOTIDES, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 33: EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR PRE-DESIGNED OLIGONUCLEOTIDES, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 34: ASIA PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR PRE-DESIGNED OLIGONUCLEOTIDES, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 35: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR REAGENTS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 36: NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR REAGENTS, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 37: EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR REAGENTS, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 38: ASIA PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR REAGENTS, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 39: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR EQUIPMENT, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 40: NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR EQUIPMENT, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 41: EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR EQUIPMENT, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 42: ASIA PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR EQUIPMENT, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 43: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 44: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 45: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 46: NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 47: EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 48: ASIA PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 49: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR PCR APPLICATIONS, BY REGION, 2015-2022 ( USD MILLION)
  • TABLE 50: NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR PCR APPLICATIONS, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 51: EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR PCR APPLICATIONS, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 52: ASIA PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR PCR APPLICATIONS, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 53: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR QPCR APPLICATIONS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 54: NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR QPCR APPLICATIONS, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 55: EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR QPCR APPLICATIONS, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 56: ASIA PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR QPCR APPLICATIONS, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 57: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR SEQUENCING APPLICATIONS, BY REGION, 2015-2022(USD MILLION)
  • TABLE 58: NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR SEQUENCING APPLICATIONS, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 59: EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR SEQUENCING APPLICATIONS, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 60: ASIA PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR SEQUENCING APPLICATIONS, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 61: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR GENE SYNTHESIS APPLICATIONS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 62: NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR GENE SYNTHESIS APPLICATIONS, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 63: EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR GENE SYNTHESIS APPLICATIONS, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 64: ASIA PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR GENE SYNTHESIS APPLICATIONS, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 65: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR OTHER RESEARCH APPLICATIONS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 66: NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 67: EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 68: ASIA PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 69: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 70: NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 71: EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 72: ASIA PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 73: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 74: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 75: NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 76: EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 77: ASIA PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 78: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR RNAI APPLICATIONS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 79: NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR RNAI APPLICATIONS, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 80: EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR RNAI APPLICATIONS, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 81: ASIA PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR RNAI APPLICATIONS, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 82: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR NUCLEIC ACID APTAMER APPLICATIONS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 83: NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR NUCLEIC ACID APTAMER APPLICATIONS, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 84: EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR NUCLEIC ACID APTAMER APPLICATIONS, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 85: ASIA PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR NUCLEIC ACID APTAMER APPLICATIONS, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 86: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR DNA/ANTISENSE OLIGO APPLICATIONS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 87: NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR DNA/ANTISENSE OLIGO APPLICATIONS, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 88: EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR DNA/ANTISENSE OLIGO APPLICATIONS, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 89: ASIA PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR DNA/ANTISENSE OLIGO APPLICATIONS, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 90: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR IMMUNOTHERAPY APPLICATIONS, BY REGION, 2015-2022 (USD THOUSAND)
  • TABLE 91: NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR IMMUNOTHERAPY APPLICATIONS, BY COUNTRY, 2014-2021 (USD THOUSAND)
  • TABLE 92: EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR IMMUNOTHERAPY APPLICATIONS, BY COUNTRY, 2015-2022 (USD THOUSAND)
  • TABLE 93: ASIA PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR IMMUNOTHERAPY APPLICATIONS, BY COUNTRY, 2015-2022 (USD THOUSAND)
  • TABLE 94: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER,2015-2022 (USD MILLION)
  • TABLE 95: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 96: NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 97: EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 98: ASIA PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 99: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 100: NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 101: EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 102: ASIA PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 103: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR DIAGNOSTIC LABORATORIES, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 104: NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 105: EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 106: ASIA PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 107: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR OTHER END USERS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 108: NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR OTHER END USERS, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 109: EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR OTHER END USERS, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 110: ASIA PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR OTHER END USERS, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 111: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 112: NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 113: NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 114: NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR SYNTHESIZED OLIGONUCLEOTIDES, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 115: NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR SYNTHESIZED OLIGONUCLEOTIDES, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 116: NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 117: NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 118: NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 119: NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 120: US: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 121: US: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR SYNTHESIZED OLIGONUCLEOTIDES, BY PRODUCT 2015-2022 (USD MILLION)
  • TABLE 122: US: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR SYNTHESIZED OLIGONUCLEOTIDES, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 123: US: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 124: US: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 125: US: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 126: US: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 127: CANADA: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 128: CANADA: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR SYNTHESIZED OLIGONUCLEOTIDES, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 129: CANADA: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR SYNTHESIZED OLIGONUCLEOTIDES, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 130: CANADA: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 131: CANADA: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 132: CANADA: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 133: CANADA: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 134: EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 135: EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 136: EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR SYNTHESIZED OLIGONUCLEOTIDES, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 137: EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR SYNTHESIZED OLIGONUCLEOTIDES, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 138: EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 139: EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 140: EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 141: EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 142: GERMANY: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 143: GERMANY: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR SYNTHESIZED OLIGONUCLEOTIDES, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 144: GERMANY: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR SYNTHESIZED OLIGONUCLEOTIDES, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 145: GERMANY: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 146: GERMANY: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 147: GERMANY: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 148: GERMANY: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 149: FRANCE: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 150: FRANCE: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR SYNTHESIZED OLIGONUCLEOTIDES, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 151: FRANCE: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR SYNTHESIZED OLIGONUCLEOTIDES, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 152: FRANCE: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 153: FRANCE: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 154: FRANCE: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 155: FRANCE: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 156: UK: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 157: UK: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR SYNTHESIZED OLIGONUCLEOTIDES, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 158: UK: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR SYNTHESIZED OLIGONUCLEOTIDES, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 159: UK: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 160: UK: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 161: UK: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 162: UK: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 163: ROE: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 164: ROE: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR SYNTHESIZED OLIGONUCLEOTIDES, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 165: ROE: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR SYNTHESIZED OLIGONUCLEOTIDES, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 166: ROE: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 167: ROE: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 168: ROE: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 169: ROE: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 170: ASIA PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 171: ASIA PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 172: ASIA PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR SYNTHESIZED OLIGONUCLEOTIDES, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 173: ASIA PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR SYNTHESIZED OLIGONUCLEOTIDES, BY TYPE,2015-2022 (USD MILLION)
  • TABLE 174: ASIA PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 175: ASIA PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 176: ASIA PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 177: ASIA PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 178: CHINA: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 179: CHINA: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR SYNTHESIZED OLIGONUCLEOTIDES, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 180: CHINA: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR SYNTHESIZED OLIGONUCLEOTIDES, BY TYPE 2015-2022 (USD MILLION)
  • TABLE 181: CHINA: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 182: CHINA: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 183: CHINA: OLIGONUCLEOTIDE MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 184: CHINA: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 185: JAPAN: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 186: JAPAN: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR SYNTHESIZED OLIGONUCLEOTIDES, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 187: JAPAN: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR SYNTHESIZED OLIGONUCLEOTIDES, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 188: JAPAN: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 189: JAPAN: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 190: JAPAN: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 191: JAPAN: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 192: INDIA: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 193: INDIA: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR SYNTHESIZED OLIGONUCLEOTIDES, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 194: INDIA: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR SYNTHESIZED OLIGONUCLEOTIDES, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 195: INDIA: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 196: INDIA: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 197: INDIA: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 198: INDIA: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 199: ROAPAC: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 200: ROAPAC: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR SYNTHESIZED OLIGONUCLEOTIDES, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 201: ROAPAC: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR SYNTHESIZED OLIGONUCLEOTIDES, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 202: ROAPAC: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 203: ROAPAC: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 204: ROAPAC: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 205: ROAPAC: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 206: LATIN AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 207: LATIN AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 208: LATIN AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR SYNTHESIZED OLIGONUCLEOTIDES, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 209: LATIN AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR SYNTHESIZED OLIGONUCLEOTIDES, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 210: LATIN AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 211: LATIN AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 212: LATIN AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 213: LATIN AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 214: BRAZIL: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 215: BRAZIL: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 216: BRAZIL: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 217: MEXICO: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 218: MEXICO: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 219: MEXICO: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 220: ROLATAM: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 221: ROLATAM: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 222: ROLATAM: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 223: MIDDLE EAST & AFRICA: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 224: MIDDLE EAST & AFRICA: OLIGONUCLEOTIDE SYNTHESIS FOR SYNTHESIZED OLIGONUCLEOTIDES, BYPRODUCT, 2015-2022 (USD MILLION)
  • TABLE 225: MIDDLE EAST & AFRICA: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR SYNTHESIZED OLIGONUCLEOTIDES, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 226: MIDDLE EAST & AFRICA: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 227: MIDDLE EAST & AFRICA: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 228: MIDDLE EAST & AFRICA: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 229: MIDDLE EAST & AFRICA: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 230: EXCHANGE RATES (USED FOR THE CONVERSION OF EUR TO USD)

LIST OF FIGURES

  • FIGURE 1: RESEARCH DESIGN
  • FIGURE 2: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 3: DATA TRIANGULATION METHODOLOGY
  • FIGURE 4: SYNTHESIZED OLIGONUCLEOTIDES SEGMENT TO DOMINATE THE GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET DURING THE FORECAST PERIOD
  • FIGURE 5: INTERMEDIATE-SCALE SYNTHESIS OLIGONUCLEOTIDES SEGMENT TO REGISTER THE HIGHEST GROWTH (2017-2022)
  • FIGURE 6: CUSTOM OLIGOS TO DOMINATE THE OLIGONUCLEOTIDE SYNTHESIS MARKET
  • FIGURE 7: RESEARCH APPLICATIONS TO DOMINATE THE OLIGONUCLEOTIDE SYNTHESIS MARKET IN 2017
  • FIGURE 8: DIAGNOSTIC LABORATORIES END USER SEGMENT TO REGISTER THE HIGHEST CAGR (2017-2022)
  • FIGURE 9: NORTH AMERICA TO HOLD THE LARGEST SHARE IN 2017 AND ASIA PACIFIC TO WITNESS THE HIGHEST GROWTH (2017-2022)
  • FIGURE 10: INCREASING RESEARCH ACTIVITIES AND GROWTH IN THE FIELDS OF MOLECULAR DIAGNOSTICS AND NGS ARE DRIVING MARKET GROWTH
  • FIGURE 11: PRIMERS TO FORM THE MAJOR CONTRIBUTING SEGMENT OF THE SYNTHESIZED OLIGONUCLEOTIDES MARKET (2017-2022)
  • FIGURE 12: CUSTOM OLIGOS TO DOMINATE THE SYNTHESIZED OLIGONUCLEOTIDES MARKET FROM 2017 TO 2022
  • FIGURE 13: PCR TO COMMAND THE LARGEST SHARE OF THE EUROPEAN RESEARCH APPLICATIONS MARKET IN 2017
  • FIGURE 14: RNAI SEGMENT TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 15: DIAGNOSTIC LABORATORIES TO WITNESS HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
  • FIGURE 16: CHINA TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD
  • FIGURE 17: OLIGONUCLEOTIDE SYNTHESIS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 18: OLIGONUCLEOTIDE SYNTHESIS MARKET: INDUSTRY TRENDS
  • FIGURE 19: SYNTHESIZED OLIGONUCLEOTIDES TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 20: ASIA PACIFIC TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD
  • FIGURE 21: CUSTOM OLIGONUCLEOTIDES TO COMMAND THE LARGEST SHARE OF SYNTHESIZED OLIGONUCLEOTIDES MARKET IN 2016
  • FIGURE 22: DIAGNOSTIC APPLICATIONS SEGMENT OFFERS LUCRATIVE GROWTH OPPORTUNITIES DURING THE FORECAST PERIOD
  • FIGURE 23: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2017 VS. 2022
  • FIGURE 24: ASIA PACIFIC TO REGISTER HIGHEST CAGR IN THE OLIGONUCLEOTIDE SYNTHESIS MARKET FOR ACADEMIC RESEARCH INSTITUTES
  • FIGURE 25: NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET SNAPSHOT
  • FIGURE 26: EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET SNAPSHOT
  • FIGURE 27: ASIA PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET SNAPSHOT
  • FIGURE 28: LATIN AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET SNAPSHOT
  • FIGURE 29: MIDDLE EAST & AFRICA: OLIGONUCLEOTIDE SYNTHESIS MARKET SNAPSHOT
  • FIGURE 30: KEY PLAYERS ADOPTED ORGANIC AS WELL AS INORGANIC GROWTH STRATEGIES BETWEEN 2014 AND 2017
  • FIGURE 31: MARKET EVOLUTION FRAMEWORK
  • FIGURE 32: GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SHARE ANALYSIS, BY KEY PLAYER, 2016
  • FIGURE 33: MERCK KGAA: COMPANY SNAPSHOT
  • FIGURE 34: EUROFINS SCIENTIFIC GROUP: COMPANY SNAPSHOT
  • FIGURE 35: THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT
  • FIGURE 36: AGILENT TECHNOLOGIES: COMPANY SNAPSHOT
  • FIGURE 37: KANEKA: COMPANY SNAPSHOT
  • FIGURE 38: GENERAL ELECTRIC COMPANY (GE): COMPANY SNAPSHOT
  • FIGURE 39: NITTO DENKO GROUP: COMPANY SNAPSHOT
  • FIGURE 40: GENSCRIPT: COMPANY SNAPSHOT
Back to Top